ECTE Projected Dividend Yield

Echo Therapeutics Inc ( OTCBB : ECTE )

Echo Therapeutics is a medical device company with a focus on advanced skin permeation technology. Co. is developing a non-invasive, wireless continuous glucose monitoring (CGM) system for initial use in the diabetes outpatient market. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. Co. has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications.

20 YEAR PERFORMANCE RESULTS